Dojolvi is usually taken orally in the form of a liquid. The general instructions for use are as follows:

• Measure the dose carefully using the provided measuring device.

• Take it with food to help with absorption.

• Divide the dose as prescribed by your healthcare provider, typically into two doses per day.

• Shake the bottle well before use to ensure the medication is evenly mixed.

• Store the medication as directed, usually at room temperature, and away from excessive heat or moisture.

If a dose is missed, take it as soon as possible unless it’s close to the time for the next dose. Do not take two doses at once to make up for a missed dose.

Doxil contains doxorubicin, a chemotherapy agent that works by interfering with the DNA inside cancer cells. This prevents the cells from replicating and growing. Specifically, doxorubicin works by:

1. Inhibiting DNA Replication: Doxorubicin blocks the activity of topoisomerase II, an enzyme necessary for DNA replication. By inhibiting this enzyme, Doxil prevents the cancer cell from dividing and growing.
   
   
2. Interfering with RNA Synthesis: The drug also interferes with the transcription process of DNA into RNA, further hindering cancer cell growth and proliferation.
   
   
3. Increasing Cell Death: Because of these effects, cancer cells are more likely to die, which slows or stops the progression of the tumor.
   
   

The liposomal formulation of Doxil helps reduce side effects because it allows the drug to accumulate more in the cancerous tissue, sparing healthy cells from exposure to high concentrations of the drug. This is particularly beneficial in minimizing the damage to tissues like the heart, which is a common concern with traditional doxorubicin.

Like all chemotherapy medications, Doxil can cause side effects, some of which can be serious. Common and severe side effects include:

Common Side Effects:

• Fatigue: Feeling tired or weak is a common side effect of chemotherapy.
• Nausea and Vomiting: These symptoms are frequent with many chemotherapy drugs, including Doxil.
• Mouth Sores: Chemotherapy can irritate the mouth, leading to sores, difficulty swallowing, and dry mouth.
• Hair Loss: Although less severe than with traditional chemotherapy, some hair loss may still occur.
• Skin Reactions: Redness, swelling, or irritation at the injection site can occur, and some people may experience skin discoloration.

Serious Side Effects:

• Heart Damage: Doxil can cause heart problems, including congestive heart failure. This is particularly a concern in people with pre-existing heart conditions. Regular heart function monitoring is required during treatment.
  
  
• Severe Allergic Reactions: Rarely, people may have an allergic reaction to Doxil, with symptoms like difficulty breathing, swelling of the face or throat, or rash. This requires immediate medical attention.
  
  
• Low Blood Counts: Doxil can lower the number of red blood cells, white blood cells, and platelets in the blood, leading to anemia, infection, or increased bleeding risk.
  
  
• Liver Toxicity: In some cases, Doxil can cause liver damage, and liver function should be monitored regularly during treatment.
  
  
• Severe Skin Reactions: Some people may develop painful skin ulcers, blisters, or peeling skin.
  
  

If any of these serious side effects occur, it’s important to contact a healthcare provider immediately.

Before starting treatment with Doxil, there are several important warnings and precautions to consider:

• Pre-existing Heart Conditions: People with a history of heart disease or heart failure should discuss their heart health with their doctor before starting Doxil. Heart function is monitored regularly during treatment.
  
  
• Pregnancy and Breastfeeding: Doxil can be harmful to a developing fetus and should not be used during pregnancy unless the potential benefits outweigh the risks. It is also not recommended for breastfeeding.
  
  
• Infections: Chemotherapy drugs like Doxil can lower your white blood cell count, making it easier for infections to develop. People receiving Doxil should avoid exposure to people with infections.
  
  
• Liver Function: Regular monitoring of liver function is essential, especially in patients with pre-existing liver conditions.
  
  
• Allergic Reactions: Doxil may cause severe allergic reactions, and patients should be monitored for any signs of hypersensitivity.
  

Doxil may interact with a number of medications, including other chemotherapy drugs and medications that affect the heart or liver. Some important interactions include:

• Other Chemotherapy Drugs: Using Doxil in combination with other chemotherapy medications may increase the risk of severe side effects, such as low blood cell counts or damage to the heart. Your healthcare provider will adjust doses accordingly.
  
  
• Heart Medications: Doxil can cause heart problems, and using it with medications that also affect the heart (such as beta-blockers, calcium channel blockers, or other chemotherapy agents like trastuzumab) can increase the risk of heart-related side effects.
  
  
• Liver Enzyme Inhibitors: Certain drugs that affect the liver, including those used to treat HIV, can interact with Doxil and alter its effectiveness. Your doctor may need to adjust your dose or monitor you more closely during treatment.
  
  
• Anticoagulants: Doxil may increase the risk of bleeding, especially when taken with blood-thinning medications, such as warfarin or aspirin.
  

The exact dosage of Doxil depends on several factors, including the type of cancer being treated, the patient’s medical condition, and how they respond to the treatment. Doxil is typically administered by intravenous (IV) infusion by a healthcare professional.

• For Ovarian Cancer: Doxil is often given as a single IV infusion of 50 mg/m² of body surface area, typically every 28 days (once every 4 weeks).
  
  
• For Breast Cancer: The usual dose is 60 mg/m² of body surface area, administered once every 3 weeks.
  
  
• For Kaposi’s Sarcoma: The dose is typically 20 mg/m² once every 2 to 3 weeks.
  
  

The treatment schedule can vary depending on the type of cancer, patient tolerance, and any side effects that may occur during treatment. Doxil is usually given in combination with other chemotherapy agents for certain types of cancer.

Doxil is a prescription-only medication. It can only be administered under the supervision of a healthcare professional, usually in a hospital or clinic setting.

1. What is Doxil used for?

• Doxil is a liposomal formulation of doxorubicin used to treat certain cancers, including ovarian cancer, AIDS-related Kaposi sarcoma, multiple myeloma, and other solid tumors as indicated.

2. What is the active ingredient in Doxil?

• Doxorubicin (liposomal formulation).

3. How does Doxil work in the body?

• It intercalates DNA and inhibits topoisomerase II, disrupting cancer cell replication; the liposomal encapsulation alters tissue distribution and may affect toxicity.

4. What forms does Doxil come in?

• It is an injectable IV infusion formulation (liposomal doxorubicin in a diluent).

5. How is Doxil administered?

• IV infusion, typically administered over a set period (e.g., 30–60 minutes) every 2–4 weeks, as prescribed.

6. How long does it take to see benefits from Doxil?

• Response varies by cancer type and patient; some responses occur after a few cycles of therapy.

7. What are common side effects?

• Nausea, vomiting, mucositis, hand-foot syndrome (palmar-plantar erythrodysesthesia), fatigue, hair loss, low blood counts, nephrotoxicity is less common with liposomal form; infusion reactions.

8. Are there serious risks with Doxil?

• Yes: myelosuppression (low blood counts), hand-foot syndrome, cardiotoxicity (careful monitoring of heart function), liver toxicity, infusion reactions, and secondary malignancies in long-term use.

9. Can Doxil interact with other medications?

• Potential interactions exist, especially with other chemotherapy, radiation, or cardiotoxic drugs; inform your oncology team of all meds.

10. Is Doxil safe during pregnancy?

• Doxorubicin-containing regimens are generally avoided in pregnancy unless clearly needed; discuss risks with a oncologist.

11. How is cardiac risk monitored with Doxil?

• Baseline and periodic Echo or MUGA scans to monitor left ventricular ejection fraction; monitor for signs of heart failure.

12. How is Doxil stored?

• Store vials refrigerated at 2–8°C (36–46°F) and protect from light; allow to reach room temperature before administration.

13. Can children receive Doxil?

• Use in pediatric patients is possible in certain cancers under specialized pediatric oncology protocols; dosing and safety monitored by a pediatric oncologist.

14. What should I do if I miss a treatment session?

• Schedule and administer as directed by your oncologist; do not skip cycles without medical guidance.

15. What are signs of an infusion reaction?

• Flushing, fever, chills, shortness of breath, rash, or chest tightness; report immediately.

16. How is Doxil different from standard doxorubicin?

• Liposomal formulation alters distribution, may reduce some toxicities (e.g., nephrotoxicity) but does not eliminate cardiotoxicity; dosing differs.

17. Can Doxil cause hair loss?

• Yes, like many chemotherapies, it can cause hair thinning or loss.

18. What should I tell my doctor before starting Doxil?

• All medications and supplements, existing heart disease, liver disease, kidney disease, prior anthracycline exposure, prior radiation, pregnancy status, and allergies.

19. Is there a risk of secondary cancers with Doxil?

• Long-term chemotherapy carries a risk of secondary malignancies, though this is relatively rare; discuss risk with your oncologist.

20. Where can I find more information or support during treatment?

• Your oncology team, cancer support groups, and patient information resources from cancer organizations.